On April 3, 2024, IQ Bar, Inc. closed the transaction. The transaction included participation from 20 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.57 USD | +0.13% | -5.72% | +63.08% |
05-20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
05-14 | Enliven Therapeutics Q1 Loss Narrows | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.08% | 1.06B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics, Inc. announced that it has received $90.000014 million in funding